Furamag®
Furamag®
Active substance: Furaginum solubile
Indications: Acute and recurring urinary tract infections
Dose and quantity: 25 mg N30; 50 mg N30
Pharmaceutical form: Capsules
Product ATC Code: J01XE
Product Description
Antibacterial agent belonging to the nitrofuran group.
Furamag® is efficient against the most common pathogens causing urinary tract infections, for instance, E. coli.
The use of Furamag®, does not develop a clinically significant resistance of micro – organisms.
Therapeutic indications:
- Treatment of urinary tract infections:
– cystitis, urethritis, pyelonephritis
- Prevention of the recurrence of urinary tract infections
- Prevention of urinary tract infections:
– in patients with long – term use of a urinary catheter (spinal patients, patients after stroke)
– before and after urological surgeries (prostatic cancer) and manipulations (in cases of cystoscopy
or catheterisation)
- Treatment of prostatitis and gynaecological infections